» Articles » PMID: 21037481

Deficits in Muscle Strength, Mass, Quality, and Mobility in People with Chronic Obstructive Pulmonary Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Midthigh intramuscular fat (IF), a feature of reduced muscle quality, is an important predictor of self-reported mobility loss in the elderly. This study compared measures of muscle strength, mass, IF, and mobility in patients with chronic obstructive pulmonary disease (COPD) and healthy subjects. Associations between measures of muscle strength, mass, IF, and mobility were explored.

Methods: Knee extensor muscle strength was assessed with an isokinetic dynamometer. Cross-sectional area and IF of the thigh muscles were measured with computerized tomography. Mobility was assessed with the repetitive sit-to-stand, self-selected gait speed, and 6-minute walk tests.

Results: Patients with COPD (n = 21, age 71.3 ± 8.1 years, and a percentage predicted force expiratory volume in 1 second of 47.2 ± 12.9) and 21 healthy subjects matched for age (67.4 ± 8.6 years), gender, and body mass participated in the study. Patients with COPD showed reduced average knee extensor strength (29%, P = .016) cross-sectional area of the thigh muscles (17%, P = .007) and mobility measures (~23%, P ≤ .001). Knee extensor and flexor IF was 2-folds greater in people with COPD (P ≤ .005). Measures of knee extensor muscle strength, mass, and IF were not associated with mobility measures.

Conclusions: Compared with healthy controls, patients with moderate to severe COPD show marked deficits in muscle strength, mass, quality, and mobility. More studies with larger sample size are required to elucidate whether any of these muscle deficits can explain mobility impairments in COPD.

Citing Articles

Association between chronic respiratory diseases and frailty in Chinese elderly: a population-based longitudinal study.

Guo D, Huang K, Guan X, Ding R, Zhu D, Zhao Y BMJ Open Respir Res. 2025; 12(1.

PMID: 39753242 PMC: 11752046. DOI: 10.1136/bmjresp-2023-002171.


Nocturnal Hypoxemia Is Associated with Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease.

Attaway A, Mehra R, Zein J, Hatipoglu U, Grund M, Orsini E Ann Am Thorac Soc. 2024; 21(9):1316-1325.

PMID: 38843487 PMC: 11376365. DOI: 10.1513/AnnalsATS.202312-1062OC.


Gait differences between COPD and healthy controls: systematic review and meta-analysis.

Buekers J, Delgado-Ortiz L, Megaritis D, Polhemus A, Breuls S, Buttery S Eur Respir Rev. 2024; 33(172.

PMID: 38657998 PMC: 11040389. DOI: 10.1183/16000617.0253-2023.


Multidimensional Frailty Instruments Can Predict Acute Exacerbations Within One Year in Patients with Stable Chronic Obstructive Pulmonary Disease: A Retrospective Longitudinal Study.

Wei L, Li P, Liu X, Wang Y, Tang Z, Zhao H Int J Chron Obstruct Pulmon Dis. 2024; 19:859-871.

PMID: 38596204 PMC: 11001541. DOI: 10.2147/COPD.S448294.


Laboratory and free-living gait performance in adults with COPD and healthy controls.

Buekers J, Megaritis D, Koch S, Alcock L, Ammour N, Becker C ERJ Open Res. 2023; 9(5).

PMID: 37753279 PMC: 10518872. DOI: 10.1183/23120541.00159-2023.


References
1.
Manini T, Clark B, Nalls M, Goodpaster B, Ploutz-Snyder L, Harris T . Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr. 2007; 85(2):377-84. DOI: 10.1093/ajcn/85.2.377. View

2.
Washburn R, Smith K, Jette A, Janney C . The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993; 46(2):153-62. DOI: 10.1016/0895-4356(93)90053-4. View

3.
Visser M, Goodpaster B, Kritchevsky S, Newman A, Nevitt M, Rubin S . Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005; 60(3):324-33. DOI: 10.1093/gerona/60.3.324. View

4.
Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-55. DOI: 10.1164/rccm.200703-456SO. View

5.
Brusasco V, Crapo R, Viegi G . Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005; 26(1):1-2. DOI: 10.1183/09031936.05.00034205. View